Screener
Vir Biotechnology, Inc. VIR Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s total liabilities?
- Vir Biotechnology, Inc. (VIR) reported total liabilities of $232.31M in Q2 2026.
- How has Vir Biotechnology, Inc.'s total liabilities changed year-over-year?
- Vir Biotechnology, Inc.'s total liabilities decreased by 5.2% year-over-year, from $245.06M to $232.31M.
- What is the long-term trend for Vir Biotechnology, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s total liabilities has grown at a 3.3% compound annual growth rate (CAGR), from $201.91M to $237.55M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Vir Biotechnology, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude